- Home
- AEVA vs GPCR Comparison
AEVA vs GPCR Comparison
Compare AEVA & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEVA
- GPCR
- Stock Information
- Founded
- AEVA 2019
- GPCR 2016
- Country
- AEVA United States
- GPCR United States
- Employees
- AEVA N/A
- GPCR N/A
- Industry
- AEVA Auto Parts:O.E.M.
- GPCR
- Sector
- AEVA Consumer Discretionary
- GPCR
- Exchange
- AEVA Nasdaq
- GPCR Nasdaq
- Market Cap
- AEVA 1.0B
- GPCR 1.1B
- IPO Year
- AEVA N/A
- GPCR 2023
- Fundamental
- Price
- AEVA $25.82
- GPCR $20.97
- Analyst Decision
- AEVA Buy
- GPCR Strong Buy
- Analyst Count
- AEVA 6
- GPCR 7
- Target Price
- AEVA $16.20
- GPCR $75.83
- AVG Volume (30 Days)
- AEVA 2.0M
- GPCR 823.9K
- Earning Date
- AEVA 08-06-2025
- GPCR 08-07-2025
- Dividend Yield
- AEVA N/A
- GPCR N/A
- EPS Growth
- AEVA N/A
- GPCR N/A
- EPS
- AEVA N/A
- GPCR N/A
- Revenue
- AEVA $10,326,000.00
- GPCR N/A
- Revenue This Year
- AEVA $94.59
- GPCR N/A
- Revenue Next Year
- AEVA $165.22
- GPCR N/A
- P/E Ratio
- AEVA N/A
- GPCR N/A
- Revenue Growth
- AEVA 95.90
- GPCR N/A
- 52 Week Low
- AEVA $2.20
- GPCR $13.22
- 52 Week High
- AEVA $26.76
- GPCR $49.91
- Technical
- Relative Strength Index (RSI)
- AEVA 78.16
- GPCR 41.43
- Support Level
- AEVA $21.90
- GPCR $20.27
- Resistance Level
- AEVA $18.69
- GPCR $24.05
- Average True Range (ATR)
- AEVA 1.82
- GPCR 1.24
- MACD
- AEVA 0.33
- GPCR -0.14
- Stochastic Oscillator
- AEVA 90.96
- GPCR 18.52
About AEVA Aeva Technologies Inc.
Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.